Atlas Trials

A Study to Evaluate the Pharmacokinetics and Safety of DBPR108 in Subjects With Renal Impairment

Clinical trial NCT04859439 · COMPLETED

Trial details

NCT number
NCT04859439
Sponsor
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Renal Impairment
Start date
2021-06-15
Primary completion
2021-11-30
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.